切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (04) : 445 -449. doi: 10.3877/cma.j.issn.1674-6902.2019.04.009

论著

斯钙素-1在慢性阻塞性肺疾病平滑肌增殖中的作用研究
许家艳1, 杨捷1, 乔云飞1, 杨俊俊1(), 徐兴祥1,()   
  1. 1. 225001 扬州,扬州大学临床医学院江苏省苏北人民医院呼吸与危重症医学科
  • 收稿日期:2019-04-11 出版日期:2019-08-20
  • 通信作者: 杨俊俊, 徐兴祥
  • 基金资助:
    江苏省苏北人民医院院基金项目(yzucms201907)

Effect of Stanniocalcin-1 on proliferation of airway smooth muscle in mice with chronic obstructive pulmonary disease

Jiayan Xu1, Jie Yang1, Yunfei Qiao1, Xingxiang Xu1,()   

  1. 1. Department of Respiratory and Critical Care Medicine, Northern Jiangsu People′s Hospital, Clinical Medical School of Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2019-04-11 Published:2019-08-20
  • Corresponding author: Xingxiang Xu
引用本文:

许家艳, 杨捷, 乔云飞, 杨俊俊, 徐兴祥. 斯钙素-1在慢性阻塞性肺疾病平滑肌增殖中的作用研究[J]. 中华肺部疾病杂志(电子版), 2019, 12(04): 445-449.

Jiayan Xu, Jie Yang, Yunfei Qiao, Xingxiang Xu. Effect of Stanniocalcin-1 on proliferation of airway smooth muscle in mice with chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(04): 445-449.

目的

探讨斯钙素-1(Stanniocalcin-1, STC1)对慢性阻塞性肺疾病(COPD)平滑肌增殖的影响及STC1在COPD气道重塑中的作用。

方法

采用臭氧暴露法构建COPD小鼠模型,选取BALB/c雌性小鼠24只,将小鼠随机分为4组:1周空气对照组(简称1周空气组)、1周臭氧暴露组(简称1周臭氧组)、3周空气对照组(简称3周空气组)、3周臭氧暴露组(简称3周臭氧组),每组6只。HE染色观察肺部炎症、肺泡间距及基底膜厚度。采用免疫组织化学法(简称免疫组化)检测小鼠肺组织α-平滑肌动蛋白(α-SMA)及STC1表达。采用2%及10%胎牛血清刺激人原代平滑肌细胞增殖,外源加入重组STC1(rhSTC1)处理平滑肌细胞,EdU染色检测平滑肌细胞增殖。

结果

臭氧暴露诱导小鼠肺部炎症、肺气肿及气道重塑发生(肺组织基底膜增厚及平滑肌细胞标志物α-SMA表达增加)。STC1主要表达在支气管上皮顶端膜,且在COPD小鼠中表达升高(P<0.05),但随着臭氧暴露3周,肺组织STC1较α-SMA表达下降(P<0.05)。外源加入rhSTC1抑制了平滑肌细胞增殖(P<0.01)。

结论

支气管上皮表达的STC1能够抑制平滑肌细胞增殖,外源给予足量的STC1可能延缓COPD气道重塑的发生。

Objective

To investigate the effect of Stanniocalcin-1 (STC1) on the proliferation of airway smooth muscle and explore the possible role of STC1 in the airway remodeling in the mice with chronic obstructive pulmonary disease (COPD).

Methods

COPD mice model was established by ozone (O3) exposure. Twenty-four BALB/c female mice were randomly divided into four groups (n=6): 1-week control (1WC) group, 1-week O3 exposed (1WO3) group, 3-week control (3WC) group and 3-week O3 exposed (3WO3) group. Hematoxylin-eosin (HE) staining was employed to observe the pulmonary inflammation, the alveolar spacing and the basement membrane thickness. Immunohistochemistry technique was used to detect the expression of α-SMA and STC1 in the lung tissues of the mice. Simultaneously, human airway smooth muscle cells (HASMCs) were stimulated by 2% and 10% FBS, respectively. The HASMCs were then treated with recombinant STC1 (rhSTC1). The proliferation of HASMCs was detected by EdU staining.

Results

O3 exposure could induce pulmonary inflammation, emphysema and airway remodeling in the mice (basement membrane thickening and increased expression of smooth muscle cell marker α-SMA). Immunohistochemical analysis demonstrated that STC1 expression showed intense staining in the apical membrane of the bronchial epithelial cells and was increased in the O3-exposed mice. However, with O3 exposure for 3 weeks, the expression of STC1 in the lung tissues decreased compared with that of α-SMA. And rhSTC1 added the inhibition of the proliferation of smooth muscle cells.

Conclusion

STC1 expression in the bronchial epithelium can inhibit the proliferation of airway smooth muscle cells. Adequate STC1 administration may delay the occurrence of airway remodeling in the mice with COPD.

图1 小鼠病理学检测结果;注:A: 1周空气组和1周臭氧组;B: 3周空气组和3周臭氧组(HE×200)。*P<0.05,**P<0.01,***P<0.001
图2 小鼠基底膜厚度;注:A:1周空气组和1周臭氧组;B:3周空气组和3周臭氧组(HE×200) ;箭头指示基底膜。*P<0.05
图3 小鼠肺组织中α-SMA的表达水平;注:A:1周空气组和1周臭氧组;B:3周空气组和3周臭氧组(HE×400) ;箭头指示α-SMA表达部位。**P<0.01
图4 小鼠支气管上皮STC1的表达水平;注:A:1周空气组和1周臭氧组;B:3周空气组和3周臭氧组(HE×200) ;箭头指示STC1表达部位。*P<0.05
图5 小鼠肺组织中STC1/α-SMA的水平。*P<0.05
图6 STC1对平滑肌细胞增殖的影响;注:A:Edu染色检测STC1对平滑肌增殖的影响;B:SPSS20.0计算EdU染色。**P<0.01,***P<0.001
1
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary[J]. Eur Respir J, 2017, 49(3). pii: 1700214.
3
Yan F, Gao H, Zhao H, et al. Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease[J]. J Transl Med, 2018, 16(1): 262.
4
Fischer KD, Agrawal DK. Vitamin D regulating TGF-beta induced epithelial-mesenchymal transition[J]. Respir Res, 2014, 15: 146.
5
Hong W, Peng G, Hao B, et al. Nicotine-Induced Airway Smooth Muscle Cell Proliferation Involves TRPC6-Dependent Calcium Influx Via alpha7 nAChR[J]. Cell Physiol Biochem, 2017, 43(3): 986-1002.
6
Wagner GF, Hampong M, Park CM, et al. Purification, characterization,and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius[J]. Gen Comp Endocrinol, 1986, 63(3): 481-491.
7
Huang L, Zhang L, Ju H, et al. Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury[J]. Sci Rep, 2015, 5: 18117.
8
Zlot C, Ingle G, Hongo J, et al. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor[J]. J Biol Chem, 2003, 278(48): 47654-47659.
9
许家艳,孟亚奇,贾 嫚,等. 人支气管上皮细胞表达的斯钙素-1在上皮间充质转化中的作用研究[J]. 南京医科大学学报(自然科学版), 2018, 38(9): 1198-1203.
10
Zhang Y, Shan P, Srivastava A, et al. Endothelial Stanniocalcin 1 Maintains Mitochondrial Bioenergetics and Prevents Oxidant-Induced Lung Injury via Toll-Like Receptor 4[J]. Antioxid Redox Signal, 2019, 30(15): 1775-1796.
11
Hirota N, Martin JG. Mechanisms of airway remodeling[J]. Chest, 2013, 144(3): 1026-1032.
12
Rasmussen JE, Sheridan JT, Polk W, et al. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction [J]. J Biol Chem, 2014, 289(11): 7671-7681.
13
Xiang J, Guo R, Wan C, et al. Regulation of Intestinal Epithelial Calcium Transport Proteins by Stanniocalcin-1 in Caco2 Cells[J]. Int J Mol Sci, 2016, 17(7):pii: E1095.
14
Ono M, Ohkouchi S, Kanehira M, et al. Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1[J]. Mol. Ther., 2015, 23(3): 549-560.
[1] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[2] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[3] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[4] 赖乾德, 吕相琴, 蔺洋, 刘媛梅, 赵春艳, 李琦. 肝素结合蛋白对慢性阻塞性肺疾病预后预测分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 613-616.
[5] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[6] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[7] 郭少琳, 郭建英, 左秀萍, 高苗. 慢性阻塞性肺疾病康复训练依从性影响因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 652-654.
[8] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[9] 杨坤, 赵景成, 吴永强. 无创呼吸机在慢性阻塞性肺疾病并发呼吸衰竭救治的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 481-483.
[10] 孙晓容, 刘佳铭, 刘禹. 以单侧肺起病的继发性重症间质性肺病的综合管理一例[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 499-501.
[11] 孔令梅, 徐晓媛, 马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 407-410.
[12] 袁广琴, 朱珠, 林云霞. 胸腺肽联合无创正压通气救治AECOPD并发Ⅱ型呼吸衰竭患者的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 438-441.
[13] 徐艳, 江秀娟, 王超, 江圆满. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 454-457.
[14] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
[15] 何秀, 敖的, 杨郑, 林小华. 改良呼吸支持策略对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者的疗效[J]. 中华卫生应急电子杂志, 2024, 10(03): 140-144.
阅读次数
全文


摘要